ERBB2 and breast carcinoma: The human epidermal growth factor receptor-2 (HER2, NEU, and c-ERBB-2) is a cell surface receptor tyrosine kinase that is strongly up-regulated in more than 15% of all breast cancers (1), and breast cancer patients with HER2 overexpressing tumors have poor prognosis (2, 3).